Roche

Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms
Fierce Pharma
Wed, 02/9/22 - 10:56 pm
Roche
Vabysmo
drug launches
Bill Anderson
Eylea
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Fierce Biotech
Wed, 02/9/22 - 10:07 am
Ventus Therapeutics
Novartis
Roche
funding
inflammation
Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis
MedCity News
Tue, 02/8/22 - 09:52 am
Endeavor BioMedicines
taladegib
cancer
Eli Lilly
Roche
idiopathic pulmonary fibrosis
Roche, Novartis CEOs pull down $12M-plus each in 2021 pay
Fierce Pharma
Thu, 02/3/22 - 11:22 pm
Roche
exeuctiva pay
Roche regains pre-pandemic sales footing, highlights bursting pipeline — with one key failure
Endpoints
Thu, 02/3/22 - 11:09 pm
Roche
earnings
pandemic
A year of TIGIT (and Alzheimer’s) for Roche
EP Vantage
Thu, 02/3/22 - 10:53 am
Roche
Tigit
tiragolumab
Alzheimer's disease
Biogen buys into fast-advancing Roche cancer drug
BioPharma Dive
Tue, 02/1/22 - 11:30 pm
Biogen
Roche
lymphoma
cancer
CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say
Fierce Pharma
Tue, 02/1/22 - 10:50 am
CMS
Biogen
Aduhelm
Eli Lilly
Roche
Alzheimer's disease
Roche grabs FDA okay for would-be blockbuster eye drug faricimab
Pharmaforum
Mon, 01/31/22 - 10:51 am
Roche
faricimab
Eylea
Bayer
Regeneron
FDA
Roche looks to compete against a blockbuster with its newly approved vision drug
Stat
Sun, 01/30/22 - 11:53 am
Roche
FDA
bispecific antibodies
Regeneron
Vabysmo
wet age-related macular degeneration
diabetic macular edema
Court ruling on bluebird bio’s gene therapy marketing campaign 'sparks' dismay at Roche's Spark
Fierce Pharma
Thu, 01/27/22 - 10:38 am
Bluebird Bio
gene therapy
sickle cell disease
Roche
Spark Therapeutics
Roche's aim to widen Evrysdi's label nabs speedy FDA review in young spinal muscular atrophy patients
Fierce Pharma
Tue, 01/25/22 - 10:54 am
Roche
Evrysdi
risdiplam
FDA
spinal muscular atrophy
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Roche sees cause for optimism with failed Huntington's disease drug. Others aren't so sure.
BioPharma Dive
Sat, 01/22/22 - 02:18 pm
Roche
clinical trials
Huntington's disease
Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington's trial
Fierce Biotech
Tue, 01/18/22 - 10:30 am
Roche
Ionis Pharmaceuticals
tominersen
Huntington's disease
clinical trials
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
Roche Taps Glytec for Digital Health Partnership
Medical Devices and Diagnostics Industry
Thu, 01/13/22 - 07:22 am
Roche
Glytec
digital health
Medtech
devices
JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor
Fierce Biotech
Wed, 01/12/22 - 11:12 am
JPMHC 2022
BeiGene
Ionis Pharmaceuticals
Roche
devices
AstraZeneca
Biogen
Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps
MedCity News
Wed, 01/12/22 - 10:59 am
Freenome
Roche
diagnostics
colorectal cancer
JPM22, Day 2: Freenome passes $1B funding mark; Amgen spices things up with Arrakis; Sage touts double-duty anxiety drug
Fierce Biotech
Tue, 01/11/22 - 11:43 am
JPMHC 2022
Freenome
Amgen
Roche
ThermoFisher Scientific

Pages